Skip to Main Content
Don't have an account? Create Account
x
Don't have an account? Create Account
Loading more articles
policy

CDC says Americans who tested positive no longer must isolate for five days under certain conditions; FDA grants emergency use authorization to the first at-home test detecting both the flu and COVID-19.

view more »
policy

Paxlovid will no longer be authorized for emergency use after March 8; V-safe, the CDC's vaccine safety monitoring system, is once again open.

view more »
policy

CDC reports no clear link between COVID-19 oral antiviral treatment and reduced risk of infection rebound as JN.1 cases rise; COVAX comes to an end after distributing nearly 2 billion COVID-19 vaccine doses.

view more »
policy

The CDC launched the National Wastewater Surveillance Program to detect traces of infectious diseases as COVID-19 hospitalizations increase for the third week in a row.

view more »
policy

A CDC advisory committee recommends providers wear masks during routine check-ups to prevent the spread of respiratory infections; FDA advises providers to ensure they administer the correct vaccination dosage to youth.

view more »
policy

Health care provider resources include strategies for talking with patients about flu, COVID-19, and respiratory syncytial virus vaccines.

view more »
policy

FDA approves Moderna and Pfizer-BioNTech's updated COVID-19 vaccines, and HHS announces $1.4 billion for Project NextGen.

view more »
quality

CDC notifies health care providers about a monoclonal antibody and two vaccines that can prevent respiratory syncytial virus infection.

view more »
quality

Health care providers should send suspected isolates to a public health laboratory and promptly initiate antibiotic therapy or surgical intervention.

view more »
quality

Ahead of Sepsis Awareness Month in September, CDC provides seven core elements to guide the creation of hospital sepsis management programs.

view more »
policy

HHS will host the Aug. 24 webinar to gather input from a variety of health care stakeholders on hospital preparedness before, during, and after emergencies.

view more »
cdc, cms, hhs
policy

HHS announced the formation of the Office of Long COVID Research and Practice to lead the long COVID response as EG.5 subvariant cases increase.

view more »
policy

The CDC Bridge Access Program will provide no-cost COVID-19 vaccines to uninsured and underinsured adults following the end of the COVID-19 Vaccine Distribution Program; the GAO released a new report outlining recommendations for future public health emergency preparedness.

view more »
policy

CDC reports that roughly three-fourths of all Americans aged 16 and older had contracted COVID-19 by the end of 2022; the agency also reports new data showing the disproportionate effect of COVID-19 on the lowest-income communities.

view more »
policy

Starting Oct. 1, Medicaid and the Children’s Health Insurance Program will cover only COVID-19 vaccines that have been fully approved by the Food and Drug and Administration.

view more »
policy

Moderna seeks FDA authorization for an updated vaccine, Invivyd announces a pathway to potential emergency use authorization for the monoclonal antibody adintrevimab, and the CDC tracks a new subvariant, EU.1.1.

view more »
policy

A CDC study confirms that a third mRNA vaccine is safe for children; FDA grants marketing authorization for the Cue at-home COVID-19 test.

view more »
policy

Two CDC studies indicate that adults who have not received a bivalent mRNA booster vaccine have little remaining protection against COVID-19–associated hospitalization and that half of Americans aged 16 and up have hybrid immunity against the virus.

view more »
policy

After months of back and forth between Republican lawmakers and the White House, President Joe Biden signs legislation to suspend the debt ceiling through 2024. The bill does not include work requirements for Medicaid recipients, a condition Republicans had sought early in negotiations.

view more »
policy

This legislation effectively postpones the debt ceiling issue for two years, dispelling concerns of a potential financial catastrophe. This Action Update summarizes the legislation and provisions of interest to essential hospitals.

view more »
policy

A World Health Organization advisory group recommends using the XBB subvariant in future vaccines; the National Institute for Occupational Safety and Health recalls eight respirators.

view more »
policy

An HHS fact sheet details policy changes with the end of the COVID-19 public health emergency; ASPR announces Project NextGen; CDC says the Johnson & Johnson vaccine no longer is available in the United States.

view more »
policy

The World Health Organization has ended the COVID-19 global health emergency designation, and the CDC will use hospitalization data to track COVID-19 spread.

view more »
policy

FDA amends the Pfizer vaccine authorization for immunocompromised children aged 6 months to 4 years old, while the Biden administration ends its vaccine requirement for federal employees.

view more »
policy

CDC simplifies vaccine recommendations for all age groups; a new HHS program supports COVID-19 vaccines and treatments for uninsured Americans.

view more »
quality

Amid two international outbreaks of the rare but highly fatal viral hemorrhagic fever, CDC provides virus identification and biosafety recommendations.

view more »
policy

Both the CDC and World Health Organization now recommend just one bivalent booster dose for healthy adults and children with no immunocompromising conditions.

view more »
quality

The agency calls the rapid rise and geographic spread of Candida auris concerning and emphasizes the need for surveillance, expanded lab capacity, quicker diagnostic testing, and adherence to infection prevention and control.

view more »
institute

The April 13 webinar will highlight how health care institutions can advance climate-informed patient care, climate mitigation, and community climate resilience.

view more »
policy

A bivalent vaccine that protects against SARS-CoV-2 and influenza will not be available this year, while a CDC advisory committee says there is not enough evidence to recommend more than one annual COVID-19 booster for immunocompromised people.

view more »
quality

Shigella infections caused by extensively drug-resistant strains comprise about 5 percent of Shigella infections reported to CDC.

view more »
policy

National Institutes of Health research finds that Black and Hispanic Americans face greater long COVID-19 risks, the CDC says that primary series vaccination protects children ages 3–5 for four months, and Novavax will deliver an additional 1.5 million doses.

view more »
policy

The CDC updated the 2023 immunization schedule for children and adolescents to include the COVID-19 primary vaccine series, and the FDA cleared for commercial distribution a device that detects 15 respiratory viral and bacterial infections.

view more »
quality

A CDC report finds that patients receiving dialysis treatment for end-stage kidney disease, especially Hispanic patients, are at an increased risk of contracting Staphylococcus aureus bloodstream infections.

view more »
policy

FDA no longer requires a positive COVID-19 test to receive a Paxlovid or Lagevrio prescription; CDC reports that bivalent boosters protect against XBB and XBB.1.5 SARS-Co-V-2 subvariants.

view more »
policy

FDA's Vaccines and Related Biological Products Advisory Committee votes to replace the original monovalent COVID-19 vaccine, Evusheld no longer is authorized under emergency use, and the CDC launches a COVID-19 testing locator.

view more »
policy

An FDA committee will vote on the future of the COVID-19 vaccine, while CDC unveils two trackers for COVID-19, flu, and RSV–related hospital and emergency department visits.

view more »
policy

The National Institutes of Health launches the Home Test to Treat program; FDA and CDC report a COVID-19 vaccine safety concern for those ages 65 and older.

view more »
policy

FDA and CDC say Evusheld is unlikely to neutralize the XBB.1.5 subvariant, and a CDC report indicates COVID-19 vaccination in children and adolescents is highest among Asian and Hispanic youth. 

view more »
policy

Registration is open now for the two Climate Change and Cardiovascular Disease Collaborative webinars on Jan. 12, at noon ET, and Feb. 9, at noon ET.

view more »
policy

FDA approves the use of Actemra, a monoclonal antibody treatment, as COVID-19 cases caused by the XBB.1.5 subvariant of SARS-CoV-2 spike.

view more »
policy

CDC expands its recommendation for bivalent COVID-19 vaccines for children ages 6 months to 5 years old as health agencies confront low vaccination rates among children.

view more »
policy

FDA pauses its emergency use authorization of bebtelovimab, which does not protect against prevalent SARS-CoV-2 subvariants; CDC updates its guidance for managing COVID-19 in congregate living settings to align with previous guidance.

view more »
policy

Pfizer-BioNTech and Moderna data indicate that bivalent vaccines provide greater protection than the original monovalent vaccine against the emerging BQ.1.1 omicron subvariant, while the CDC reports low COVID-19 vaccination numbers among children.

view more »
quality

The agency shares toolkits to help acute-care, long-term care, and ambulatory care facilities adopt the Four Moments of Antibiotic Decision Making framework.

view more »
policy

A JAMA Network open study highlights disparities in access to Test-to-Treat sites; the Biden administration holds a White House COVID-19 Equity Summit.

view more »
policy

A new report from the Department of Veterans Affairs indicates that Paxlovid can reduce risk of long COVID-19; new data show Pfizer bivalent COVID-19 booster vaccines substantially increase immune responses compared with monovalent vaccines.

view more »
policy

President Joe Biden urges Americans to get their updated COVID-19 vaccine, which protects against the original SARS-CoV-2 variant and BA.4 and BA.5 subvariants.

view more »
policy

A CDC committee recommends the inclusion of COVID-19 vaccines in the 2023 immunization schedule; the administration releases a biodefense strategy.

view more »
policy

CDC recommends for younger age groups updated Pfizer and Moderna COVID-19 booster vaccines that target the BA.4 and BA.5 subvariants of SARS-CoV-2.

view more »
policy

HHS links COVID-19 vaccinations to fewer COVID-19 hospitalizations and deaths, and NIH details its plan to study long COVID-19 effects.

view more »
policy

CDC issued a health advisory reminding health care providers to remain aware of a patient’s international travel history.

view more »
policy

CDC updates guidance on infection control for health care personnel and staff shortages, as well as its global pandemic response strategy.

view more »
policy

CDC reports lower in-hospital mortality rates from the omicron variant, providers have until Sept. 30 to report period 3 Provider Relief Fund spending.

view more »
policy

The Biden administration encourages organizations to commit to working toward its goal of ending hunger and increasing healthy eating and physical activity by 2030.

view more »
policy

CDC recommends updated Pfizer and Moderna COVID-19 booster vaccines that target the BA.4 and BA.5 subvariants of SARS-CoV-2.

view more »
policy

No-cost, at-home COVID-19 tests no longer will be offered through the United States Postal Service, CDC releases a fall vaccination plan, and FDA warns prescribers about Paxlovid drug interactions.

view more »
policy

Pfizer applies for emergency use authorization for its omicron-specific booster vaccine, the National Healthcare Safety Network will take over hospital data reporting, and CMS tells hospitals to brace for the public health emergency's end.

view more »
policy

CDC updated its COVID-19 safety guidelines, FDA warned of false negative test risks, and bebtelovimab will transition to the commercial marketplace.

view more »
policy

HHS agreed to purchase 66 million Moderna bivalent COVID-19 vaccine doses, while the CDC reported fewer vaccine reactions for those older than 50 who receive a second mRNA booster shot.

view more »
policy

As the World Health Organization declares monkeypox a global health emergency, CDC updates clinical guidance, and HHS plans to allocate additional vaccine doses.

view more »
policy

CDC recommends the Novavax COVID-19 vaccine for adults and reports that additional mRNA COVID-19 vaccine booster doses increase protection against moderate and severe COVID-19.

view more »
quality

Antimicrobial-resistant hospital-onset infections and deaths both increased from 2019 to 2020, according to a new CDC analysis.

view more »
policy

The strategy aims to deploy vaccines rapidly in the most affected communities, facilitate testing, and engage stakeholders to mitigate spread.

view more »
policy

The HHS Office of Climate Change and Health Equity announced a climate change webinar series, beginning July 14, and shared a companion resource compendium.

view more »
policy

CDC recommends the Moderna vaccine for kids ages 6 to 17; an FDA committee will consider modifying COVID-19 vaccine composition to reflect virus mutations.

view more »
policy

CDC recommends that children ages 6 months to 5 years receive a COVID-19 vaccine; Pfizer study data shows Paxlovid failed to alleviate COVID-19 symptoms.

view more »
state-action

The Florida Department of Health does not recommend COVID-19 vaccines for "healthy children" and will not facilitate statewide vaccine distribution; health care providers still may order vaccines directly from the federal government.

view more »
policy

CDC is tracking monkeypox, a virus endemic to west and central Africa, after confirming a case in a Massachusetts resident who recently traveled to Canada.

view more »
policy

Pfizer and BioNTech release promising data on a three-dose COVID-19 vaccine for children six months to younger than 5; CDC expands booster shot eligibility to include everyone 5 years old and older.

view more »
policy

FDA limits authorized use of the Janssen COVID-19 vaccine after reports of thrombosis with thrombocytopenia syndrome following vaccination; a new analysis estimates vaccines are associated with $2.6 million in savings due to a reduction in Medicare hospitalizations.

view more »
policy

A new omicron subvariant, BA.2.12.1, constitutes more than 30 percent of U.S. genomic sequences; Moderna files for emergency use authorization for a vaccine for children younger than 6.

view more »
policy

Moderna releases promising preliminary data on its variant-specific COVID-19 booster shot; CDC launches a Center for Forecasting and Outbreak Analytics.

view more »
policy

President Joe Biden announces a national research plan on prolonged illness developed after COVID-19; FDA limits authorization of sotrovimab to treat COVID-19.

view more »
policy

CDC recommends an additional COVID-19 booster for older and immunocompromised adults; COVID.gov aggregates COVID-19 prevention and treatment tools; CDC data show threats to youth mental health during the pandemic.

view more »
policy

FDA authorizes a second vaccine booster for older and immunocompromised individuals; OSHA reopens the comment period for its emergency temporary standard.

view more »
policy

Research shows mRNA vaccines effectively prevent ventilation and death from COVID-19; Pfizer and Moderna seek authorization for an additional booster dose.

view more »
policy

The Transportation Security Administration extends to April 18 its public transit mask mandate; HHS shares a fact sheet on the COVID-19 Test-to-Treat initiative.

view more »
policy

President Joe Biden unveils a new COVID-19 National Preparedness Plan; FEMA extends its 100 percent federal cost share for COVID-19 efforts.

view more »
policy

CDC announces a new community-level framework that assesses COVID-19 risk; the Biden administration unveils a new COVID-19 mitigation plan for people with disabilities.

view more »
policy

National emergency extended; new study highlights conditions and symptoms developed after COVID-19 infection; CDC updates vaccine guidance with clarifications for immunocompromised people.

view more »
policy

Authorization for the Pfizer COVID-19 vaccine for children six months to four years old is delayed; FDA authorizes the monoclonal antibody bebtelovimab.

view more »
policy

FDA approves the Moderna COVID-19 vaccine and limits a monoclonal antibody authorization; OSHA withdraws its vaccine mandate emergency temporary standard.

view more »
policy

The Biden administration will distribute 400 million no-cost N95 masks; CDC studies highlight the importance of boosters in protecting against COVID-19.

view more »
quality

The revised site reflects new information, partner feedback, and industry best practices and includes fact sheets on the agency's AR Laboratory Network and innovative investments to respond to AR globally.

view more »
policy

The U.S. Supreme Court upheld CMS' vaccine mandate but struck down the Occupational Safety and Health Administration's mandate; President Joe Biden announced new initiatives to expand testing access.

view more »
policy

The nomination of Robert Califf, MD, as commissioner of the Food and Drug Administration advances to the Senate floor. The Republican-led Healthy Futures Task Force issues several requests for information on telehealth policies and health care affordability.

view more »
policy

CDC shortens the time between primary vaccine series and booster shot and recommends a Pfizer booster for adolescents; the Supreme Court hears oral arguments on two vaccine mandates; HHS requires coverage of at-home COVID-19 tests, effective Jan. 15.

view more »
policy

FDA expands authorization for the Pfizer COVID-19 booster; FDA authorizes two antiviral pills; CMS updates guidance on vaccine mandate compliance.

view more »
policy

CDC recommends mRNA COVID-19 vaccines be given clinical preference over the Janssen vaccine; the CMS vaccine mandate rule is revived in 25 states.

view more »
policy

FDA authorizes the Pfizer COVID-19 vaccine booster for individuals as young as 16; the agency also authorizes a monoclonal antibody for COVID-19 prevention.

view more »
policy

As the omicron SARS-CoV-2 variant reaches the United States, President Joe Biden releases a new plan to combat COVID-19; CMS will not enforce its health care worker vaccine mandate amid legal challenges.

view more »
policy

FDA and CDC endorse expanded eligibility for Pfizer and Moderna COVID-19 booster vaccine doses; Pfizer seeks authorization for its COVID-19 antiviral pill.

view more »
policy

CDC recommends the Pfizer COVID-19 vaccine for children ages 5 to 11; CMS holds a stakeholder call on its vaccine mandate for health care workers. Pfizer says its investigational novel COVID-19 oral antiviral candidate significantly reduces hospitalization and death.

view more »
policy

FDA authorizes the Pfizer COVID-19 vaccine for use in children ages 5 to 11 and delays approval of the Moderna vaccine in adolescents ages 12 to 17. The agency recommends providers avoid purchasing or using imported medical gloves from certain companies that might be in violation of laws and rules.

view more »
policy

FDA and CDC recommend Moderna and Janssen booster vaccines, along with heterologous booster doses; the Biden administration releases a plan to vaccinate children.

view more »
policy

The Vaccines and Related Biological Products Advisory Committee endorses booster shots of the Moderna and Janssen COVID-19 vaccines. Meanwhile, FDA delays authorization of the Moderna COVID-19 vaccine for emergency use in adolescents ages 12 to 17 after reports of cardiac side effects.

view more »
policy

An HHS report shows the COVID-19 vaccine prevented hospitalization and death in Medicare beneficiaries; Pfizer applies for emergency use authorization for its vaccine in children age 5 to 11.

view more »
policy

HHS guidance clarifies how HIPAA applies to COVID-19 vaccination status requests; CDC urges pregnant people to get vaccinated amid a surge in hospitalizations.

view more »
policy

FDA on Sept. 22 authorized a third booster dose of the Pfizer-BioNTech COVID-19 vaccine for select groups. A CDC panel subsequently recommended the booster shots, and CMS announced coverage for all Medicare beneficiaries and nearly all Medicaid and Children's Health Insurance Program beneficiaries.

view more »
policy

An FDA advisory committee recommends a Pfizer COVID-19 vaccine booster for a limited population; CDC announces $2.1 billion dedicated to infection control and prevention.

view more »
policy

The president's newly announced "Path out of the Pandemic" plan includes action steps for increasing vaccinations, further protecting those who are vaccinated, keeping schools safely open, testing and mask requirements, and economic recovery. CDC updates its infection control guidance.

view more »
policy

An FDA committee will review Pfizer's COVID-19 vaccine booster application; Moderna is applying for booster approval. CDC data show COVID-19 hospitalizations on the rise among children.

view more »
policy

A CDC advisory committee voted Aug. 30 to recommend the Pfizer-BioNTech COVID-19 vaccine; the agency warns against using ivermectin to treat or prevent COVID-19.

view more »
policy

FDA approves the Pfizer-BioNTech COVID-19 vaccine. HHS plans to promote a booster shot of the mRNA vaccines beginning in September. CMS and CDC work to develop an emergency regulation requiring COVID-19 vaccination for nursing home staff.

view more »
policy

FDA and CDC recommend a third mRNA COVID-19 vaccine dose for immunocompromised people; CDC recommends COVID-19 vaccines for pregnant and breastfeeding people.

view more »
policy

CDC recommends everyone, even those who are fully vaccinated, wear a mask indoors in public in areas with substantial and high COVID-19 transmission.

view more »
policy

As COVID-19 cases rise, the association calls on members to require employee vaccination; CDC urges immunocompromised people to continue wearing masks.

view more »
policy

The U.S. Surgeon General issues a health misinformation advisory; CDC and the Office of Minority Health develop a Minority Health Social Vulnerability Index.

view more »
policy

The Occupational Safety and Health Administration extends to Aug. 20 the comment period for the COVID-19 health care emergency temporary standard. The Centers for Disease Control and Prevention and the Food and Drug Administration say fully vaccinated individuals do not need COVID-19 booster shots.

view more »
policy

The interim guidance covers physical and mental health conditions present four or more weeks after some COVID-19 infections, including by patients who initially had mild or asymptomatic acute infections.

view more »
policy

Novavax's COVID-19 vaccine demonstrated 90.4 percent efficacy in clinical trials; CDC urges vaccination upon hospital discharge.

view more »
policy

President Biden announces a National Month of Action to vaccinate 70 percent of U.S. adults by July 4; Moderna applies for FDA approval of its vaccine.

view more »
policy

FDA lengthens the refrigerator storage time for the Pfizer COVID-19 vaccine. A new CDC site aggregates state and local COVID-19 funding opportunities. The Department of Health and Human Services allocates $4.8 billion to the HRSA COVID-19 Uninsured Program.

view more »
state-action

In response to new Centers for Disease Control and Prevention guidance for fully vaccinated people, several states, including Nevada, Oregon, and Washington, have lifted their statewide mask mandates.

view more »
policy

New CDC recommendations no longer require people who are fully vaccinated against COVID-19 to wear a mask or physically distance.

view more »
policy

A CDC brief updates transmission methods; Pfizer applies for FDA approval of its vaccine; CMS increases the Medicare payment for monoclonal antibodies.

view more »
policy

New CDC guidelines walk back outdoor mask regulations for fully vaccinated people; two research studies examine adverse reactions to the Janssen COVID-19 vaccine.

view more »
policy

CDC and FDA lift the pause on Janssen vaccine administration after blood clot reports. Data show COVID-19 patients have long-term health needs.

view more »
policy

Everyone in the United States ages 16 and older is now eligible for a COVID-19 vaccine; CDC's advisory committee will meet April 23 to discuss the Janssen vaccine pause.

view more »
policy

CDC and FDA recommend pausing Janssen COVID-19 vaccine administration after six U.S. reports of blood clots; HHS expands the Health Center Vaccine Program.

view more »
policy

CDC Director Rochelle Walensky declared racism a serious public health threat and outlined agency efforts to mitigate the impact of racism on public health. The association applauds Walensky's clear statement on systemic racism.

view more »

America's Essential Hospitals thanks the Biden administration and CDC Director Rochelle Walensky for taking a strong stand on racism as a serious public health threat and for seeking to direct more investments at social determinants of health and mitigating health care disparities.

view more »
policy

HHS and CDC launch a nationwide grassroots vaccine promotion network; CDC issues new guidance on travel, cleaning, and disinfection.

view more »
policy

President Joe Biden announced initiatives to expand COVID-19 vaccine access; a CDC study shows mRNA vaccines are highly effective in preventing SARS-CoV-2 infection.

view more »
policy

In light of the COVID-19 public health emergency, CMS updated its guidance document to expand on best practices, lessons, and planning considerations for emerging infectious diseases. 

view more »
policy

FDA alerts providers about monoclonal antibody–resistant SARS-CoV-2 variants; a new study examines vaccine rates in counties where residents experience a high number of social risk factors.

view more »
policy

The Occupational Safety and Health Administration updated its COVID-19 enforcement plan; CDC updates infection control guidance for vaccinated people in health care facilities.

view more »
policy

CDC releases public health guidelines for fully vaccinated people; CMS invites hospitals to pilot a COVID-19 learning series.

view more »
policy

CDC warns health care providers to stay vigilant amid Ebola outbreaks in the Democratic Republic of the Congo and Guinea.

view more »
policy

A CDC report shows promising COVID-19 vaccine safety profiles; the federal COVID-19 task force expands support for vaccination and testing.

view more »
policy

CDC provides new vaccine demographic data and guidelines for ensuring close-fitting face masks; President Biden appoints two essential hospital leaders to a health equity task force.

view more »
policy

Janssen applied for emergency use authorization of its COVID-19 vaccine; a CDC report shows reporting gaps in ethnic and racial data of vaccine recipients.

view more »
policy

A new CDC order requires mask use on public transportation; a PREP Act amendment expands the provider groups authorized to administer vaccines.

view more »
policy

CDC requires a negative test or travel clearance from a health care professional to enter the country; President Biden issues COVID-19 national strategy and complementary executive orders.

view more »
policy

As a highly transmissible SARS-CoV-2 variant spreads across the country, CDC issues two new vaccination toolkits; HHS alters its Provider Relief Fund reporting timeline.

view more »
policy

CDC shares information about two highly contagious SARS-CoV-2 variants, allergic reactions in Pfizer vaccine recipients, and vaccines for pregnant people.

view more »
state-action

The CDC data tracker shows COVID-19 vaccine rollout has varied significantly across the country. While Connecticut, New Hampshire, and South Dakota have administered at least 60 percent for their available vaccine doses, Arizona and Georgia have not yet administered 20 percent of their vaccines.

view more »
policy

CDC announces target groups for phases 1b and 1c of COVID-19 vaccine allocation; a new brief recommends strategies for building vaccine trust.

view more »
policy

FDA issues an emergency use authorization for the Moderna vaccine and an at-home antigen test; a CDC committee votes on allocation recommendations.

view more »
policy

FDA authorizes the Pfizer COVID-19 vaccine for emergency use; HHS expands hospital COVID-19 data reporting requirements to include therapeutic data.

view more »
policy

CDC recommends groups to prioritize in vaccine distribution and revises antigen testing guidance.

view more »
policy

Moderna applied for emergency use authorization for its COVID-19 vaccine; CDC issued ethical vaccine application principles and updated face mask guidance for health care workers.

view more »
quality

The Centers for Disease Control and Prevention marks U.S. Antibiotics Awareness Week with a new Antibiotic Use Option Report that synthesizes National Healthcare Safety Network data.

view more »
policy

An interim analysis of Moderna Inc.'s COVID-19 vaccine shows promising results; CDC guidance highlights that wearing a mask can protect the wearer.

view more »
policy

FDA grants emergency use authorization for an Eli Lilly antibody treatment; a Pfizer vaccine has promising early results; President-elect Biden names a COVID-19 advisory board.

view more »
policy

The Centers for Disease Control and Prevention has updated guidance for mask use on public transportation; the Food and Drug Administration has expanded its list of approved remote patient monitoring devices during the pandemic.

view more »
policy

Hospital COVID-19 data is public on HHS Protect; FDA approves first treatment for hospitalized COVID-19 patients; CDC redefines "close contact."

view more »
policy

CDC reports that airborne transmission is rare but possible; a framework includes recommendations for equitable vaccine allocation.

view more »
policy

CMS released a guide and online payment option for laboratories seeking approval to test for COVID-19; CDC studies COVID-19 in health care workers.

view more »
policy

The Centers for Disease Control and Prevention reverses guidance that asymptomatic patients do not need to be tested. The agency also announced a new semiweekly publication summarizing COVID-19 studies.

view more »
policy

An Operation Warp Speed strategy summarizes the federal government's plan for distributing and administering a COVID-19 vaccine.

view more »
policy

More than 40 percent of U.S. adults report delaying or avoiding care due to COVID-19 fears; FDA shares vaccine development updates.

view more »
policy

The National Academies of Sciences, Engineering and Medicine released a preliminary framework for equitable allocations of a COVID-19 vaccine that rests on foundational principles, including maximizing benefits, fairness, mitigating health inequities, equal regard, evidence-based work, and transparency.

view more »
policy

CDC no longer encourages asymptomatic people to get tested; FDA expands its remdesivir emergency use authorization and authorizes a new antigen test with instant results.

view more »
policy

FDA issued an emergency use authorization for convalescent plasma treatment of COVID-19 patients, along with guidance for pooled testing and screening.

view more »
policy

HHS announces $6.5 million in testing investments; CDC issues antigen testing guidance; HHS partners with Moderna to manufacture and deliver its vaccine.

view more »
policy

CDC onboards health departments to conduct electronic data reporting; HHS awards funding to Johnson & Johnson for vaccine manufacturing and delivery.

view more »
policy

Health systems can add CDC's Coronavirus Self-Checker to their own website; HHS updates COVID-19 data reporting FAQs; CDC shares guidance on pooling tests.

view more »
policy

CDC releases a COVID-19 health equity strategy, and FDA shares options for screening substitutions amid supply issues.

view more »
policy

The HHS Coronavirus Data Hub goes live; CDC guidance recommends a symptom-based strategy for COVID-19 patients. CMS data show an increase in telehealth use among Medicare beneficiaries. The IRS extends the deadline for tax-exempt hospitals to conduct a community health needs assessment.

view more »
policy

HHS has acquired additional remdesivir to be sold at wholesale allocation price; CDC reports declining emergency department use during the pandemic and updates its list of conditions that increase risk of serious illness from COVID-19.

view more »
policy

New CDC guidance offers best practices to safely venture outside and begin to resume daily activities amid the COVID-19 pandemic, as well as information on using telehealth to expand access. CMS releases recommendations for non-emergent care in areas that are in Phase II of recovery.

view more »
policy

New guidance provides details on COVID-19 lab test data reporting and flexible options for states implementing a Medicaid group for testing the uninsured.

view more »
policy

The Joint Commission will resume regular surveys of health care facilities; Gilead Sciences Inc. donates a second round of remdesivir to treat severe COVID-19 cases; CDC issues antibody testing guidelines.

view more »
policy

CMS updates Medicare payment information to capture two new testing codes; FDA updates testing FAQs; CDC issues resources for reopening businesses and organizations.

view more »
policy

CDC warns of an inflammatory syndrome in children with COVID-19. The agency also shares its serology surveillance strategy and guidance for resuming care unrelated to COVID-19.

view more »
policy

A new study highlights racial disparities among COVID-19 patients; CDC updates testing and isolation guidelines and releases National Healthcare Safety Network data.

view more »
policy

CDC revised its testing guidance to reflect six new COVID-19 symptoms: chills, repeated shaking with chills, muscle pain, headache, sore throat, and new loss of taste or smell. HHS released a Workforce Virtual Toolkit, and CMS released a State Medicaid and CHIP Telehealth Toolkit.

view more »
policy

CMS announced waivers for IPPS and long-term care hospitals; Medicare will nearly double payment for select COVID-19 tests; CDC developed a new National Healthcare Safety Network COVID-19 module.

view more »
policy

New CDC guidance requires face coverings for all who enter a health care facility. HHS Secretary Azar issues FAQs on testing and reporting requirements. Federal agencies warn about scams related to COVID-19.

view more »
policy

HHS sends rapid tests to public health labs and issues a HIPAA enforcement notice; CDC recommends cloth masks; a new OIG report details hospital challenges amid the pandemic.

view more »
policy

FDA will not object to the use of improvised face masks; a CDC tool helps health care providers estimate their personal protective equipment supply.

view more »
policy

CMS releases guidance for hospitals in quality reporting programs; CDC updates guidelines for testing and handling COVID-19 specimens.

view more »
policy

CDC recommends shelters plan for higher usage during the outbreak and consult with community leaders, local public health departments, and faith-based organizations about places to refer clients if a shelter space is full.

view more »
policy

President Trump declared a national emergency as the number of confirmed COVID-19 cases in the U.S. nears 3,500. CMS responds to concerns about complying with Emergency Medical Treatment and Labor Act requirements and CDC released updated infection control guidance for health care providers.

view more »
state-action

The Centers for Disease Control and Prevention will use existing networks to award more than $560 million to states, localities, territories, and tribes to accelerate planning and operational readiness. The agency has issued a list of funding actions and a frequently asked questions document.

view more »
policy

As U.S. cases of the new coronavirus rise to more than 400, the agency updates guidelines for testing patients and for health care workers exposed to COVID-19.

view more »
policy

Both chambers passed a bill providing more than $8 billion to combat the new coronavirus; House leaders now are discussing legislation to mitigate economic impacts associated with the virus. A Senate letter calling to incorporate social determinants into hospital star ratings closes tomorrow.

view more »
policy

The new code applies to tests conducted outside CDC laboratories; CMS also issued frequently asked questions and fact sheets about COVID-19–related billing.

view more »
policy

These cases bring the total number of COVID-19 cases detected and confirmed in the United States to 16. The Centers for Disease Control and Prevention and the Food and Drug Administration have issued new guidance and resources to prevent the spread of the virus and improve testing.

view more »
policy

The agency announced it will count patients repatriated by the Department of State separately from other cases. Additionally, the World Health Organization developed an emergency ICD-10 code for COVID-19.

view more »
policy

The new coronavirus — now officially called COVID-19 — has infected 15 people in the United States. The Centers for Disease Control and Prevention released new guidance for health care providers to help with risk assessment, monitoring, and work restriction decisions.

view more »
policy

The new authorization allows any CDC-qualified laboratory to use the 2019-nCoV diagnostic test. Each test kit can evaluate up to 800 patient samples.

view more »
policy

A new rule allows CDC to require that airlines collect and provide data on passengers and crew arriving from foreign countries for health education, treatment, prophylaxis, or other public health interventions.

view more »
policy

Five cases of the coronavirus have been reported in the United States; CDC will host a Jan. 31 call for clinicians to share updated guidance about the virus.

view more »
quality

Health care providers should notify state and local health departments if patients have severe respiratory symptoms after traveling to Wuhan City, China.

view more »
quality

The report includes updated statistics and, for the first time, uses electronic health data from hospitals to calculate infection and death rates.

view more »
quality

The report shows a 9 percent decrease in central line–associated bloodstream infections, an 8 percent decrease in catheter-associated urinary tract infections, and a 12 percent decrease in hospital-onset Clostridium difficile infections.

view more »
quality

The update covers a wider variety of health care settings and includes guidance for the use of performance measures in infection control quality initiatives.

view more »
state-action

A new report from the National Association of County and City Health Officials and the Centers for Disease Control and Prevention explores how rural local health departments mitigate social determinants of health.

view more »
policy

Funding will support the State Opioid Response Grant Program and a cooperative agreement to help state and local governments track overdose data.

view more »
quality

The report includes resources for health care providers and profiles antibiotic stewardship efforts at association members Atrium Health and Denver Health.

view more »
quality

The Centers for Disease Control and Prevention is expecting a three- to 10-month nationwide shortage of Aplisol, used in tuberculin skin tests.

view more »
quality

Learn why cultural competency matters during emergencies, explore the potential consequences of being culturally incompetent, and gain resources to help build understanding.

view more »
quality

In response to reported hepatitis A virus outbreaks in multiple states, the agency urges health care providers to vaccinate at-risk groups, including people who use drugs and people experiencing homelessness.

view more »
institute

This funding opportunity supports the formation of Maternal Mortality Review Committees, which will work with the agency to collect and analyze maternal death data.

view more »
policy

The budget plan proposes to overhaul the Medicaid program, as well as significantly change the 340B Drug Pricing Program and expand site-neutral payment policies in hospital outpatient departments.

view more »
quality

A new Vital Signs report calls on health care providers to increase prevention efforts for Staphylococcus aureus infections.

view more »
institute

The multiyear grant opportunity seeks to test and evaluate innovative approaches to address prediabetes, as well as support enrollment and retention in the Centers for Disease Control and Prevention–recognized National Diabetes Prevention Program.

view more »
state-action

The Antibiotic Resistance Investment resource page features an interactive map and downloadable fact sheets for each state and select major cities.

view more »
quality

The modules are part of a training series based on agency guidelines for prescribing opioids for chronic pain.

view more »
quality

Essential hospitals across the country have made commitments to improve antimicrobial stewardship through the Centers for Disease Control and Prevention's Antimicrobial Resistance Challenge.

view more »
quality

A Centers for Disease Control & Prevention toolkit provides educational resources and social media messaging for Antibiotics Awareness Week 2018.

view more »
quality

These no-cost, downloadable cards include ready-to-use infection prevention assessment forms tailored to 19 common themes, environments, or patient populations.

view more »
quality

This new report, published in the Antibiotic Resistance Patient Safety Atlas, is the first to measure year-to-year health care–associated infection prevention progress using the updated 2015 baseline.

view more »
quality

This yearlong global initiative challenges governments, private industries, and nongovernmental organizations to commit to reducing antibiotic and antimicrobial resistance.

view more »
policy

This funding supports initiatives under the agency's Five-Point Opioid Strategy and was distributed in conjunction with Prescription Opioid and Heroin Epidemic Awareness Week.

view more »
policy

The Centers for Medicare & Medicaid Services waived program requirements in Virginia, North Carolina, and South Carolina; the Centers for Disease Control & Prevention issued guidance for treating carbon monoxide poisoning in hurricane victims.

view more »
policy

In a blog post, a Centers for Disease Control and Prevention official notes that providers should consider health equity during emergency preparedness, response, and recovery to ensure disparities are not inadvertently created or exacerbated.

view more »
quality

The toolkit, released as part of National Immunization Awareness Month, includes sample news releases and articles, social media content, and media outreach tools.

view more »
quality

This training details approaches to controlling antibiotic resistance in health care settings; participants must sign up for a free Medscape account.

view more »
policy

The special open-door forum aims to educate prescribers on federal resources and strategies to combat the opioid epidemic.

view more »
quality

This second segment of a no-cost, online training course focuses on outpatient antibiotic stewardship and communicating with patients; participants can receive up to eight hours of continuing education credit.

view more »
quality

The June 19 webinar features a patient perspective on environmental disinfection in dialysis stations, along with strategies for enacting best practices.

view more »
quality

The Centers for Disease Control and Prevention (CDC) has extended to June 15 the deadline to complete an Agreement to Participate and Consent.

view more »
quality

Potential topics include a broad range of health conditions, risk factors, and applications, such as public health partnerships, care coordination approaches, and data integration strategies.

view more »
quality

The agency outlines a five-step containment process and provides resources for health departments, labs, and health care providers.

view more »
quality

The Centers for Disease Control and Prevention will award up to $15.75 million for research to advance understanding about opioid overdose prevention. Applications are due May 15.

view more »
quality

The new rules allow surveyors to penalize a hospital for a deficiency if an individual fails to perform hand hygiene in the process of direct patient care.

view more »
quality

This year's theme, We Are All Patients, encourages health care providers to stand with patients and stresses the importance of patient engagement in safe care.

view more »
quality

A new CDC study finds a 30 percent increase in opioid overdose–related emergency department (ED) visits; the agency will host a webinar on coordinating clinical and public health responses to opioid overdoses treated in EDs.

view more »
quality

Health care professionals who complete the four-part web training program are eligible to receive up to eight hours of continuing education credit.

view more »
quality

Administrators must review and sign the updated agreement by April 14 to retain access to the National Healthcare Safety Network.

view more »
Essential Insights

Grady Memorial Hospital, in Atlanta, deployed the state-of-the-art mobile medical unit in an effort to free up hospital emergency department space for acute-care patients as flu season heats up.

view more »
quality

The agency has found marked progress over a decade in eliminating five health care–associated infections (HAIs), and offers an update on the Department of Health and Human Services' five-year goals to reduce HAIs.

view more »
quality

The Centers for Disease Control and Prevention will observe Antibiotics Awareness Week with a Twitter chat and webinar on Nov. 16.

view more »
policy

The emergency declaration expands telemedicine services to treat addiction and opens up the Public Health Emergency Fund, among other actions to combat the opioid crisis.

view more »
quality

These awards will support antibiotic resistance research with a focus on the human microbiome, environmental settings, and health care settings.

view more »
quality

From Oct. 15 to Oct. 21, the Association for Professionals in Infection Control and Epidemiology will raise awareness about antibiotic resistance through a Twitter chat and new infographic.

view more »
policy

The emergency operations center was activated in January 2016 to respond to the harmful effects of the virus when contracted during pregnancy.

view more »
quality

With 153 clinical C. auris cases reported in the United States, the Centers for Disease Control and Prevention issued updated infection control guidelines.

view more »
quality

This video shares strategies to improve injection safety and reduce infection risks in narcotic diversion; participants must sign up for a free Medscape account to view the video.

view more »
quality

Two free online simulations help health care providers improve decision-making skills during infectious disease outbreaks and public health emergencies.

view more »
policy

The Centers for Medicare & Medicaid Services, the Centers for Disease Control and Prevention, and other federal agencies have released several resources to help health care providers prepare for and respond to disasters.

view more »
quality

The funds will go to 44 states and the District of Columbia to expand prevention and tracking activities under the Centers for Disease Control and Prevention's Overdose Prevention in States effort.

view more »
quality

The Get Ahead of Sepsis campaign includes a partner toolkit with educational and social media materials; CDC also will host a related webinar and Twitter chat.

view more »
quality

Health professionals are encouraged to join social media campaigns, attend informational calls and webinars, and review a new fact sheet on Candida auris.

view more »
quality

The funding will support state and local health departments in testing for drug-resistant fungi and promote the use of whole genome sequencing in testing.

view more »
quality

The guidance no longer recommends routine testing of women unless there was ongoing potential exposure; the Health Resources and Services Administration awarded $7 million to fight Zika in U.S. territories.

view more »
quality

The report outlines programs implemented by hospitals and public health departments across the country to improve antibiotic prescribing practices as part of the agency's Antibiotic Resistance Solutions Initiative.

view more »
quality

The funding will be used to track and prevent opioid overdoses; meanwhile, a report finds a drop in the estimated rate of Americans misusing prescription drugs.

view more »
policy

Essential hospitals, key providers of public health and emergency preparedness services, stand ready to support the nation's response to the spreading Zika virus. Find resources from the CDC and other experts here.

view more »
quality

Despite reductions in opioid prescribing, the amount of opioids prescribed in 2015 still was triple the amount prescribed in 1999.

view more »
quality

Centers for Disease Control and Prevention data show incidence of Clostridium difficile in hospitals and nursing homes fell for the first time in decades.

view more »
quality

The video is the third in a series by the Centers for Disease Control and Prevention about challenges to preventing health care-associated infections.

view more »
policy

The findings highlight the need for continued mosquito surveillance and can help health departments and mosquito control districts plan for outbreaks.

view more »
quality

The error affects the 2015 and 2016 catheter-associated urinary tract infection predictive models; new models will be developed for affected facilities.

view more »
policy

The Vital Signs report notes ways to prevent the bacterial lung infection, which is fatal in 25 percent of people who contract it at a health care facility.

view more »
quality

This year, 77 U.S. cases of Candida auris have been reported; the Centers for Disease Control and Prevention is assisting health agencies in affected areas.

view more »
quality

Magellan Diagnostics' LeadCare Analyzers could produce inaccurate blood lead test results when used with venous blood samples.

view more »
policy

The webinar will focus on managing resources, setting priorities, engaging stakeholders, and anticipating needs during crises, such as disease outbreaks.

view more »
quality

The new guidance updates recommendations issued in 1999; recommendations are categorized based on the quality of available supporting evidence.

view more »
quality

CDC has found an increase in Shigella bacteria resistant to flouroquinone antibiotics, which could indicate resistance to other drugs.

view more »
quality

A lethal, drug-resistant fungus called Candida auris could pose the country's leading health risk.

view more »
quality

The training resource is the first in a series of eight learning modules to be released this year on the CDC opioid prescribing guidelines.

view more »
quality

The rankings provide a county-level “snapshot” of health and can help essential hospitals identify the needs of the communities they serve.

view more »
policy

The blueprint also shifts CDC funding to a $500 million block grant and creates a Federal Emergency Response Fund for public health outbreaks, like Zika.

view more »
policy

The March 22 webinar will outline the agencies' roles in the expansion of the program model, next steps for organization considering offering it & more.

view more »
quality

CDC recommends hospitals clean rooms of patients with Candida auris daily and post-discharge with a disinfectant that is effective against C. diff.

view more »
quality

CDC will host two free workshops with the National Ebola Training & Education Center to train health care workers on delivering patient care during an infectious disease epidemic.

view more »
quality

The 90-minute webinar will focus on training hospital epidemiologists in the interpersonal skills necessary to handle an infectious disease outbreak.

view more »
quality

The course runs March 20–24 in Atlanta and includes expert content on different infection or event types, as well as antibiotic stewardship.

view more »
quality

The new resources — including a mobile app, series of short videos, posters and more — are meant to help providers follow guidelines issued in March 2016.

view more »
cdc
institute

The 500 Cities Project — a collaboration between the CDC and RWJF — is bringing expanded public health data to 500 cities across the country, allowing communities to evaluate health on 27 metrics.

view more »
quality

The annual event encourages relevant stakeholders and the general public to engage in antibiotic stewardship in outpatient and inpatient settings.

view more »
quality

The study found that treatment with high-risk antibiotics made sepsis 80 percent more likely compared with patients who were not treated with antibiotics.

view more »
quality

The Clinician Outreach and Communication Activity aims to educate providers on Zika screening protocols, clinical interventions, reporting processes and more.

view more »
quality

Hospitals will have the opportunity to discuss the potential contamination of heater-cooler devices used during cardiopulmonary bypass procedures.

view more »
quality

The targets aim to significantly reduce central line-associated bloodstream infections, MRSA, Clostridium difficile cases, and other infections by 2020.

view more »
quality

Stӧckert 3T heater-cooler devices used during cardiopulmonary bypass procedures might have been contaminated with M. Chimaera in the manufacturing process.

view more »
quality

An archived recording of an Oct. 11 hospital quality call with the Centers for Disease Control and Prevention and Food and Drug Administration is now available for members of America's Essential Hospitals.

view more »
Essential Insights

If left unchecked, antibiotic-resistant infections will kill 10 million people a year and cost the worldwide economy $100 trillion by 2050.

view more »
policy

Hospitals and eligible professionals now can register to submit National Health Care Survey data in 2017.

view more »
Essential Insights

For Sepsis Awareness Month, in September, we spoke to experts at two member hospitals, Parkland Health & Hospital System and UNM Health Sciences Center, about their efforts to prevent and care for sepsis.

view more »
quality

The recommendations, developed by the Healthcare Infection Control Practices Advisory Committee, aim to optimize treatment and minimize adverse consequences.

view more »
quality

In August, CDC sent states about $2.5 million in laboratory supplies and equipment — including two diagnostic tests — to combat the Zika virus.

view more »
policy

While details are still being finalized, a continuing resolution to fund the government through early December likely will include funding to combat Zika.

view more »
policy

The funding is being administered by SAMHSA and CDC as part of HHS' Opioid Initiative, which aims to combat opioid misuse, dependence, and overdose.

view more »
quality

In a Vital Signs report ahead of Sepsis Awareness Month, in September, CDC highlights resources and events aimed at reducing sepsis.

view more »
quality

The community health initiative, called Health Impact in 5 Years, launches on Aug. 9 with an introductory web forum.

view more »
quality

Funding will support work related to CDC Antibiotic Resistance Solutions Initiative, National Action Plan for Combating Antibiotic-Resistant Bacteria.

view more »
quality

Agency expands the Zika-specific blood testing window for pregnant women from seven days after symptoms start to up to 14 days.

view more »
quality

The funds are intended for epidemiological surveillance and investigation, mosquito control and monitoring, and strengthening of laboratory capacity.

view more »
quality

The funding was distributed as part of the Prevention Epicenters Program, which aims to develop and test new approaches to patient safety and infection prevention.

view more »
quality

CDC has released a draft interim response plan for the first locally acquired Zika virus cases in the continental United States and Hawaii.

view more »
quality

CDC's June Vital Signs finds that the number of U.S. residents with Legionnaires' disease and Pontiac fever increased 286 percent from 2000 to 2014.

view more »
quality

New hospital resource offers examples of ways to fight antibiotic-resistant bacteria and outlines CDC's core elements of stewardship programs.

view more »
quality

CDC will host two webinars this month to discuss a program to educate health care professionals about the social factors that affect overall health.

view more »
quality

The CDC has launched a registry — in collaboration with state, local, tribal, and territorial health agencies — to track pregnancy and infant outcomes of women who were possibly infected with Zika.

view more »
quality

To prevent transmission of the virus, workers should use proper infection control and biosafety practices to avoid direct contact with blood-borne pathogens.

view more »
quality

To prevent spread, agency recommends personal protective equipment (PPE) for labor and delivery personnel and delays in conception, sexual activity for those with symptoms.

view more »
policy

The new recommendations are based on principles that promote alternative therapies and minimum effective opioid dosage. CDC also released fact sheets and other resources.

view more »
quality

Select laboratories nationally will have access to new diagnostic tool that enables providers to determine with one test, rather than three, whether a patient is infected with chikungunya, dengue, or Zika.

view more »
policy

FDA official notes "urgent need” to accelerate development of medical products to combat the virus and says the agency will “leverage its authorities" to aid that process.

view more »
quality

The CDC has organized two events for Patient Safety Awareness Week, March 13-19, and is releasing new patient safety–focused materials on its website.

view more »
quality

Children who have been to infected areas within past two weeks or show two or more symptoms of Zika virus should be screened for the virus.

view more »
quality

Agency says blood donors should self-defer if they show symptoms, have traveled to Zika-infected regions, or have had sexual contact with someone from an infected region.

view more »
quality

The Centers for Disease Control and Prevention (CDC) has issued a health advisory for the growing number of hemodialysis patients who are acquiring hepatitis C virus (HCV).

view more »
quality

No-fee course, Feb. 29 to March 4 in Atlanta, to focus on January 2016 updates to the NHSN patient safety component manual.

view more »
quality

Educational surveys to help CMS determine best ways to assess infection control regulations for hospitals, nursing homes, and care transitions. Surveys to begin in FY 2016 for nursing homes and in FY 2017 for hospitals.

view more »
policy

The guidance, open for a 30-day public comment period, will give providers more clarity on the appropriate use of opioid prescriptions outside of cancer and palliative care; comments are due Jan. 13.

view more »
quality

CDC report outlines the need for monitoring of CRE and related antibiotic-resistant bacteria.

view more »
policy

Obama administration proposal would add drug utilization review and restriction program to Medicare to fight opioid overuse.

view more »
quality

Week-long annual event will engage stakeholders in discussion and education about antibiotic stewardship in inpatient, outpatient, and animal health settings.

view more »
quality

Initiative seeks to strengthen healthcare-associated venous thromboembolism (VTE) prevention, raise awareness of successful strategies, and recognize investment in VTE prevention.

view more »
quality

Hospitals should assess units to ensure they are safe and properly maintained and not contaminated with non-tuberculosis mycobacterium. Patients who may have been exposed to NTM should monitor signs of potential infection for several years.

view more »
quality

Agencies say anecdotal reports of intentional nonreporting of infection data have prompted them to emphasize the importance of accurate reporting through strict adherence to NHSN definitions.

view more »
quality

The prevention epicenters will identify innovative ways to prevent the spread of infectious diseases in health care facilities. University of Utah and the University of Illinois - Chicago join Cook County Health & Hospital System as essential hospital participants.

view more »
quality

Participants will receive training and technical assistance from national community health improvement experts, engage with the new Community Health Improvement Navigator, and exchange ideas with other partnerships. Applications are due Oct. 13.

view more »
quality

CDC and FDA remove language from guidelines that requires health care facilities to verify that vendors involved in maintaining, cleaning, disinfecting, and sterilizing reusable medical devices are certified by the manufacturer.

view more »
quality

The CDC and FDA issued a health advisory alerting providers and facilities to properly maintain, clean, disinfect, and sterilize reusable medical devices. Noncompliance creates a gap in patient safety.

view more »
quality

Event, open to all providers, will focus on coordinating efforts in the fight against the increasing number of potentially life-threatening germs that resist drugs created to treat them.

view more »
Essential Insights

Honoring school nurses for National Nurses Week - showing how they provide value to the community.

view more »
quality

New online tools include maps of cases nationally and specific to outbreak linked to Disneyland resort

view more »
quality

The use of antiviral medications is especially important this season because the flu vaccine might be less effective against some versions of the virus.

view more »
policy

The panel will assess the impact of potential regulations on this exposure. The SBA seeks small business entity representatives to inform the panel.

view more »
policy

The House Committee on Foreign Affairs, Subcommittee on Africa, Global Health, Global Human Rights, and International Organizations called an emergency hearing to address the Ebola outbreak, including the capacity to contain it in the United States.

view more »
Load More
Previous Next
Close
Test Caption
Test Description goes like this